Determining health condition statuses using subcutaneous impedance measurements

US12575755B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12575755-B2
Application numberUS-202017021564-A
CountryUS
Kind codeB2
Filing dateSep 15, 2020
Priority dateSep 27, 2019
Publication dateMar 17, 2026
Grant dateMar 17, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Techniques for obtaining impedance data to provide an early warning for heart failure decompensation are described. An example device may be configured to measure subcutaneous impedance values, and increment an impedance score. In some examples, the device may use an adaptive threshold and fluid index in incrementing the impedance score. In some examples, the impedance score is compared to a threshold to determine a heart failure status of a patient. In some examples, may cause resets in fluid index values and/or determine positions or orientations of the device when determining the impedance score.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A system comprising: an insertable cardiac monitor (ICM) comprising a housing and a plurality of electrodes on the housing, wherein the ICM, the housing, and the plurality of electrodes are configured for subcutaneous implantation in a patient, wherein at least two electrodes of the plurality of electrodes are positioned within 5 centimeters (cm) apart on the housing, wherein the ICM is configured to determine one or more subcutaneous tissue impedance signals of interstitial fluid measured using only the plurality of electrodes on the housing; and processing circuitry configured to periodically: determine, based at least in part on the one or more subcutaneous tissue impedance signals, a plurality of tissue impedance values; determine, based at least in part on the plurality of tissue impedance values, one or more fluid index values; determine an adaptive threshold based on an absolute impedance value of at least one of the one or more subcutaneous tissue impedance signals; perform a comparison of the one or more fluid index values and the adaptive threshold; and determine a health condition status of the patient based at least in part on the comparison. 2 . The system of claim 1 , wherein the processing circuitry is further configured to: identify a fluid index reset condition; and reset a fluid index value of the one or more fluid index values to a baseline value in response to identifying the fluid index reset condition. 3 . The system of claim 2 , wherein the processing circuitry is configured to: receive a manual reset request; and identify the fluid index reset condition in response to receiving the manual reset request. 4 . The system of claim 2 , wherein the processing circuitry is configured to: identify a change in orientation of the ICM; determine that the change in orientation of the ICM satisfies a threshold; and identify the fluid index reset condition based at least in part on the determination that the change in orientation satisfies the threshold. 5 . The system of claim 4 , wherein the processing circuitry is configured to: determine the ICM orientation based on at least one of: a change in measured impedance values or accelerometer data. 6 . The system of claim 1 , wherein the processing circuitry is configured to: determine the health condition status satisfies a health condition worsening threshold; and generate a remediation action in response to the determination that the health condition status satisfies the health condition worsening threshold. 7 . The system of claim 6 , wherein the remediation action includes modifying a therapy. 8 . The system of claim 1 , wherein the processing circuitry is configured to: identify an occurrence of one or more missing impedance values; and interpolate or extrapolate data from the plurality of tissue impedance values to include with the plurality of tissue impedance values as interpolated or extrapolated data. 9 . The system of claim 1 , wherein the processing circuitry is configured to: determine at least one additional impedance value in response to receiving a signal from a sensor device. 10 . The system of claim 1 , wherein the processing circuitry is configured to: identify an accelerometer value; determine that the accelerometer value satisfies an orientation threshold; and determine the plurality of tissue impedance values based at least in part on the determination that the accelerometer value satisfies the orientation threshold. 11 . The system of claim 1 , wherein the processing circuitry is configured to: receive a plurality of signals using the electrodes, wherein the signals include the one or more subcutaneous tissue impedance signals and at least one electrocardiogram (ECG). 12 . The system of claim 1 , wherein the processing circuitry is configured to: receive intra-vascular impedance measurements; and determine the one or more fluid index values using one or more of the intra-vascular impedance measurements and the plurality of tissue impedance values. 13 . The system of claim 1 , wherein the processing circuitry is configured to: determine, based at least in part on the one or more subcutaneous tissue impedance signals, at least one first tissue impedance value that corresponds to a first time period; determine, based at least in part on the one or more subcutaneous tissue impedance signals, at least one second tissue impedance value that corresponds to a second time period different from the first time period; determine, based at least in part on the at least one first tissue impedance value, one or more reference impedance values; and determine the one or more fluid index values based at least in part on the one or more reference impedance values and the at least one second tissue impedance value. 14 . The system of claim 1 , wherein the at least two electrodes are positioned on the housing to face a skin layer of the patient when the ICM is subcutaneously implanted. 15 . The system of claim 1 , wherein at least two electrodes of the plurality of electrodes are separated by a fixed distance. 16 . The system of claim 1 , wherein the processing circuitry is further configured to: determine an impedance score based at least in part on the comparison; and determine the health condition status of the patient based at least in part on the impedance score. 17 . The system of claim 13 , wherein the processing circuitry is further configured to: determine the at least one second tissue impedance value is less than the one or more reference impedance values; in response to the determination that the at least one second tissue impedance value is less than the one or more reference impedance values: determine the adaptive threshold based on at least one of a mean or median of an absolute impedance value of the one or more impedance signals of subcutaneous interstitial fluid during a particular period of time, the particular period of time being within 30 days prior to the measurement of the one or more impedance signals of subcutaneous interstitial fluid; compare the one or more fluid index values to the adaptive threshold; and modify the determination of the health condition status based on the comparison of the one or more fluid index values to the adaptive threshold. 18 . A method for controlling operation of processing circuitry of a computing device comprising: determining, by using the processing circuitry, based at least in part on one or more subcutaneous tissue impedance signals of interstitial fluid, a plurality of tissue impedance values, the one or more subcutaneous tissue impedance signals of interstitial fluid being measured using only a plurality of electrodes on a housing of an insertable cardiac monitor (ICM) disposed in a subcutaneous layer of a patient, wherein at least two electrodes of the plurality of electrodes are positioned within 5 centimeters (cm) apart on the housing; determining, by using the processing circuitry, based at least in part on the plurality of tissue impedance values, one or more fluid index values determining, by using the processing circuitry, an adaptive threshold based on an absolute impedance value of at least one of the one or more subcutaneous tissue impedance signals; performing, by using the processing circuitry, a comparison of the one or more fluid index values and the adaptive threshold; and determining, by using the processing circuitry, a health condition status of the patient based at least in part on t

Assignees

Inventors

Classifications

  • Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches · CPC title

  • Heart · CPC title

  • using impedance sensors · CPC title

  • using accelerometers or gyroscopes · CPC title

  • Measuring blood output from the heart, e.g. minute volume · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12575755B2 cover?
Techniques for obtaining impedance data to provide an early warning for heart failure decompensation are described. An example device may be configured to measure subcutaneous impedance values, and increment an impedance score. In some examples, the device may use an adaptive threshold and fluid index in incrementing the impedance score. In some examples, the impedance score is compared to a th…
Who is the assignee on this patent?
Medtronic Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/0538. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).